Q1 2019 Digital Health Funding and M&A Report

2019年第一季度数字健康领域投融资及并购报告

2019-04-15 21:25:38 mercomcapital

本文共1158个字,阅读需3分钟

The report covers both consumer-centric and patient-centric technologies and sub-technologies, including: Social Health, Mobile Health (mHealth), Telehealth, Personal Health, Rating & Shopping, Health Information Management, Revenue Cycle Management, Service Providers and Security. Click here to see our complete list of technologies. Total corporate funding for Digital Health companies – including VC, debt, and public market financing – totaled $2.2 billion in Q1 2019. Venture capital (VC) funding, including private equity and corporate venture capital into Digital Health (Healthcare IT) companies in Q1 2019, came to $2 billion in 149 deals compared to $1.4 billion in 142 deals in Q4 2018. VC funding in Q1 2019 was down 19% compared to the same quarter of last year (Q1 2018) when nearly $2.5 billion was raised in 187 deals. Digital Health companies have brought in over $37 billion in disclosed VC funding since 2010. The top funded categories in Q1 2019 were: $557 million raised by Data Analytics companies, mHealth Apps with $392 million, Telemedicine with $220 million, Healthcare Booking with $177 million, Clinical Decision Support with $107 million, Mobile Wireless with $90 million and $80 million for Healthcare IT Service Providers. The top VC deals in Q1 2019 included: $170 million raised by Doctolib, $100 million from Health Catalyst, $88 million raised by Calm, and $80 million by Taimei Medical Technology. There were 48 early-round deals in Q1 2019. A total of 371 investors participated in funding deals in Q1 2019 compared to 412 investors in Q1 2018. There were 16 FDA and CE approvals issued to Digital Health companies in Q1 2019. In Q1 2019, there were 45 M&A transactions (seven disclosed) involving Digital Health companies compared to 48 M&A transactions (13 disclosed) in Q1 2018. The top disclosed M&A transactions included the $195 million acquisition of Voalte by Hill-Rom Holdings, followed by BioTelemetry’s acquisition of Geneva Healthcare for $65 million. Alphabet’s Google acquired Fossil Group’s intellectual property related to a smartwatch technology currently under development for $40 million, Netmeds acquisition of KiViHealth for $10 million and Livongo Health’s acquisition of myStrength for $10 million. A total of 610 companies and investors were covered in this report. The Q1 Digital Health (Healthcare IT) Funding and M&A Report contains annual, quarter-over-quarter (QoQ) information on market activity displayed in easy-to-digest charts, graphs and tables, as well as data-driven analysis covering: This report also contains comprehensive lists of all announced Q1: This report is 93 pages in length, contains 60 charts, graphs and tables, and covers 610 investors and companies.
该报告涵盖以消费者为中心和以病人为中心的技术和次级技术,包括:社会健康、移动健康( mHealth )、远程健康、个人健康、评级和购物、健康信息管理、收入周期管理、服务提供商和安全。单击此处查看完整的技术列表。 2019年第一季度,包括风险投资、债务和公开市场融资在内的数字健康公司的企业融资总额为22亿美元。 风险投资( VC )融资(包括私募股权和企业风险投资)于2019年第一季度进入数字健康( Healthcare IT )公司)149宗交易,金额达20亿美元,而2018年第四季度的142宗交易为14亿美元。与去年同期(2018年第一季度)相比,2019年第一季度的风险投资下降了19%,当时187笔交易筹集了近25亿美元。 自2010年以来,数字健康公司已经获得了超过370亿美元的已披露风险投资资金。 2019年第一季度的最高资助类别为:数据分析公司筹集的5.57亿美元, mHealth Apps 筹集的3.92亿美元,远程医疗2.2亿美元,医疗预订1.77亿美元,临床决策支持1.07亿美元,移动无线9000万美元,医疗 IT 服务提供商提供的8000万美元。 2019年第一季度最大的风险投资交易包括: Doctolib 筹集的1.7亿美元、 Health Catalyst 筹集的1亿美元、 Calm 筹集的8800万美元以及 TaimeMedical Technology 筹集的8000万美元。 2019年第一季度有48笔早期交易。 2019年第一季度共有371名投资者参与了融资交易,而2018年第一季度有412名投资者参与。2019年第一季度向数字健康公司颁发了16个 FDA 和 CE 认证。 2019年第一季度,涉及数位生公司的并购交易(已披露7宗)为45宗,而2018年第一季度的并购交易(已披露13宗)为48宗。 披露最多的并购交易包括 Hill-Rom Holdings 对 Voalte 的1.95亿美元收购,其次是 BioTelemetric 以6500万美元收购 Geneva Healthcare 。Alphabet 的谷歌以4000万美元收购了 Fossil Group 与智能手表技术相关的知识产权, Netmed 以1000万美元收购了 KiViHealth , Livongo Health 以1000万美元收购了 MyStrength 。 本报告共涉及610家公司和投资者。 Q1数字健康(医疗保健 IT )融资和并购报告包含市场活动的年度、季度环比( QoQ )信息,这些信息显示在易于理解的图表、图表和表格中,以及数据驱动的分析,涵盖: 本报告还载有所有宣布的第一季度的综合清单: 本报告篇幅93页,包含60张图表、图表和表格,涉及610家投资者和公司。

以上中文文本为机器翻译,存在不同程度偏差和错误,请理解并参考英文原文阅读。

阅读原文